May 3 | Digital Health: Clinical Evidence and Patient Impact

Register below for ANDHealth and Novartis’ “Digital Health: Clinical Evidence and Patient Impact”

 

Register Here

 


Digital Health: Clinical Evidence and Patient Impact
Date: 3rd of May
Time: 9:30am – 11:30am
Location: 54 Waterloo Rd, Macquarie Park NSW
Cost: Free

ANDHealth and Novartis are delighted to welcome international digital health leader Anand Iyer, Co-Founder & Chief Strategy Officer, WellDoc. Anand is most known for his insights and experience with technology, strategy and regulatory policy. Anand has been instrumental in WellDoc’s success and the development of BlueStar®, the first FDA-cleared mobile prescription therapy for adults with type 2 diabetes.

As a foundation member and ANDHealth’s exclusive pharmaceutical partner, Novartis is working with ANDHealth to advance the commercialisation of evidence-based digital health technologies in Australia, to change the way we deliver healthcare and to provide patients with better health outcomes.

Numbers are limited so register you and your team today.

 

Keynote Speaker: Anand Ayer PhD, MBA
Co-Founder & Chief Strategy Officer, WellDoc on “Crossing the Boundary Between Technology and Therapeutics”  

 

                                                                Program

9:30 am Welcome
9:40 am -10.20 am Keynote Address – Crossing the Boundary Between Technology and Therapeutics

Anand Iyer, Co-Founder & Chief Strategy Officer, WellDoc

10.20 am – 10.45 am Strengthening Australia’s digital health sector

Bronwyn Le Grice, Co-Founder, CEO & Managing Director, ANDHealth

10.45 am – 11.05 am Transforming healthcare through digital health – a tech and patient perspective

Perx Health and Seer Medical

 11.05 am – 11.20 am The broader digital health landscape

Federico Girosi, Chief Scientist and Director of Research, Digital Health CRC

 11.20 am – 11.30 am Australia’s National Digital Health Showcase

Health Horizon


Register Here

ANDHealth Admin